Stevens Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$773K Buy
668
+167
+33% +$197K 0.13% 85
2026
Q2
$601K Buy
501
+277
+124% +$283K 0.11% 87
2026
Q1
$206K Buy
224
+26
+13% +$26.4K 0.05% 124
2025
Q4
$213K Buy
+198
New +$189K 0.06% 98

Other funds holding LLY

Stevens Capital Partners's LLY Position: Q3 2026 in Review

Stevens Capital Partners increased its Eli Lilly (LLY) stake by 33% in Q3 2026, buying an estimated $197K and bringing the position to 668 shares worth $773K. The position accounts for 0.13% of the portfolio, ranked #85.

Stevens Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Stevens Capital Partners held 668 shares of Eli Lilly worth $773K as of Q3 2026.
  • Stevens Capital Partners bought 167 Eli Lilly shares in Q3 2026, an estimated $197K.
  • Eli Lilly made up 0.13% of Stevens Capital Partners's portfolio in Q3 2026, its #85 holding.
  • Stevens Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Stevens Capital Partners's 13F filing for Q3 2026, filed 29 Oct 2026.